PNC Financial Services Group
JUNO

PNC Financial Services Group’s Juno Therapeutics, Inc. JUNO Stock Holding History

PNC Financial Services Group’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,515
Closed -$70K – 4381
2017
Q4 		$70K Buy
1,515
+142
+10% +$7.08K ﹤0.01% 2759
2017
Q3 		$62K Sell
1,373
-195
-12% -$6.65K ﹤0.01% 2813
2017
Q2 		$46K Hold
1,568
– – ﹤0.01% 2951
2017
Q1 		$35K Buy
1,568
+10
+0.6% +$214 ﹤0.01% 3063
2016
Q4 		$29K Sell
1,558
-342
-18% -$8.37K ﹤0.01% 3086
2016
Q3 		$58K Buy
1,900
+1,100
+138% +$34.2K ﹤0.01% 2764
2016
Q2 		$32K Buy
800
+200
+33% +$8.3K ﹤0.01% 3055
2016
Q1 		$24K Sell
600
-400
-40% -$13.9K ﹤0.01% 3205
2015
Q4 		$45K Buy
1,000
+191
+24% +$9.47K ﹤0.01% 2900
2015
Q3 		$32K Sell
809
-3,991
-83% -$175K ﹤0.01% 3143
2015
Q2 		$256K Buy
4,800
+4,000
+500% +$212K ﹤0.01% 2056
2015
Q1 		$48K Sell
800
-1,300
-62% -$63.1K ﹤0.01% 3070
2014
Q4 		$109K Buy
+2,100
New +$94K ﹤0.01% 2427

Other funds holding JUNO

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

PNC Financial Services Group's JUNO Position: Q1 2018 in Review

PNC Financial Services Group sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 1,515 shares — an estimated $70K sold.

PNC Financial Services Group first reported a position in JUNO in Q4 2014 and held it in 13 quarters. The position peaked at $256K in Q2 2015. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • PNC Financial Services Group reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • PNC Financial Services Group sold 1,515 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $70K.
  • PNC Financial Services Group first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 13 quarters.
  • PNC Financial Services Group's Juno Therapeutics, Inc. position peaked at $256K in Q2 2015.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on PNC Financial Services Group's 13F filing for Q1 2018, filed 11 May 2018.